3170
M. Okazaki et al. / Bioorg. Med. Chem. 20 (2012) 3162–3172
cel); solvent, 35% EtOH in hexane; flow rate, 5 mL minꢀ1; detec-
tion, 254 nm. The materials at tR 29.5-32.5 and 36.7–40.5 min were
collected to give (+)-Abz-E1 (12.9 mg) and (ꢀ)-Abz-E1 (13.6 mg),
respectively, with an optical purity of each 99.9%. (+)-Abz-E1:
(+)-Abz-E2B, 5.6 mg). Although the sign of the rotation of Abz-
E2B in each diastereomer was specified in parentheses to avoid
confusion, it was yet unknown at this time and determined by
identifying the rotational sign of Abz-E2B released from the MTPA
esters (see Section 4.3.4). 1H NMR (500 MHz, CDCl3): diastereomer
A (R-MTPA-(+)-Abz-E2B): d 0.74 (9H, s, t-butyl), 0.90 (3H, t,
J = 7.3 Hz, –O CH2CH2CH2CH3), 1.35 (2H, m, –OCH2CH2CH2CH3),
½
a 2D3
ꢂ
+18.6 (MeOH, c 0.860); (ꢀ)-Abz-E1: ½a D23
ꢀ23.7 (MeOH, c
ꢂ
0.907). 1H NMR and HRMS data of optically pure Abz-E1 agreed
with those of racemic Abz-E1.
1.56 (2H, m, –OCH2CH2CH2CH3), 3.47 (2H, t, J = 6.6 Hz,
–
4.3.2. Preparation of optically pure Abz-E2B
OCH2CH2CH2CH3), 3.60-3.77 (11H, m, 4 ꢁ –CH2O– and –OMe),
4.81 (2H, s, 1,2,3-triazole-CH2O–), 6.15 (1H, s, H-3), 7.26 (1H, s,
H-1), 7.44 (3H, m, phenyl in MTPA), 7.60 (2H, m, phenyl in MTPA),
7.67 and 7.87 (each 2H, m, 1-phenyl), 7.82 and 7.94 (each 1H, s,
1,2,4-triazole), 8.09 (1H, s, 1,2,3-triazole); diastereomer B (R-
MTPA-(ꢀ)-Abz-E2B): d 0.67 (9H, s, t-butyl), 0.90 (3H, t, J = 7.3 Hz,
–O CH2CH2CH2CH3), 1.36 (2H, m, –OCH2CH2CH2CH3), 1.56 (2H,
m, –OCH2CH2CH2CH3), 3.47 (2H, t, J = 6.6 Hz, –OCH2CH2CH2CH3),
3.51 (3H, s, –OMe), 3.60-3.77 (11H, m, 4 ꢁ –CH2O–), 4.81 (2H, s,
1,2,3-triazole-CH2O–), 6.21 (1H, s, H-3), 7.35 (1H, s, H-1), 7.48
(3H, m, phenyl in MTPA), 7.60 (2H, m, phenyl in MTPA), 7.68 and
7.86 (each 2H, m, 1-phenyl), 7.80 and 8.08 (each 1H, s, 1,2,4-tria-
zole), 8.09 (1H, s, 1,2,3-triazole). Protons of 1,2,4-triazole and
1,2,3-triazole were assigned on the basis of an HMBC correlation:
-N-CH@C(N@N–)-CH2O–.
(+)-Abz-E2B (3.6 mg) and (ꢀ)-Abz-E2B (5.1 mg) were prepared
from (+)-Abz-E1 (10 mg) respectively in the same manner as ( )-
Abz-E2B. (+)-Abz-E2B: 1H NMR (270 MHz, CDCl3): d 0.68 (9H, s,
t-butyl), 0.90 (3H, t, J = 7.5 Hz, –OCH2CH2CH2CH3), 1.36 (2H, m, –
OCH2CH2CH2CH3), 1.56 (2H, m, –OCH2CH2CH2CH3), 3.46 (2H, t,
J = 6.6 Hz, –OCH2CH2CH2CH3), 3.61–3.77 (8H, m, –OCH2CH2OCH2-
CH2O–), 4.35 (1H, d, J = 8.9 Hz, HO-3), 4.60 (1H, d, J = 8.9 Hz, H-3),
4.80 (2H, s, 1,2,3-triazole-CH2O–), 7.00 (1H, s, H-1), 7.56 (2H, m,
1-phenyl), 7.82 (2H, m, 1-phenyl), 8.07 (1H, s, 1,2,4-triazole),
8.08 (1H, s, 1,2,3-triazole), 8.54 (1H, s, 1,2,4-triazole); 13C NMR
(67.8 MHz, CDCl3): d 13.9 (–OCH2CH2CH2CH3), 19.3 (–OCH2CH2
CH2CH3), 26.1 (methyls in t-butyl), 31.7 (–OCH2CH2CH2CH3), 36.3
(tertiary carbon in t-butyl), 64.7, 70.0, 70.1, 70.6, and 70.7 (diethyl-
ene glycol linker), 71.2 (–OCH2CH2CH2CH3), 75.8 (C3), 120.6 (1,2,3-
triazole), 120.7 (phenyl), 127.5 (C1), 130.3 (phenyl), 134.3 (phe-
nyl), 136.7 (phenyl), 137.8 (C2), 143.2 (1,2,4-triazole), 146.4
(1,2,3-triazole), 151.7 (1,2,4-triazole); HRMS (ESI-TOF, positive
4.3.4. Hydrolysis of the diastereomers A and B
To a stirred solution of the diastereomer A (5.6 mg, 7.8 lmol) in
mode): calcd for
C
26H38N6O4Na [M+Na]+ 521.2852, found
MeOH (1.2 mL) was added 1 M NaOH (1 mL). After stirred for 1.5 h,
1 M HCl (1.5 mL) was added to quench the reaction. The resulting
mixture was extracted with EtOAc (8 mL ꢁ 3). The organic layer
was washed with brine, dried over Na2SO4, and concentrated in va-
cuo. The residual oil was purified by silica gel column chromatog-
raphy with 5% MeOH in CH2Cl2 to obtain a crude oil containing
Abz-E2B. The crude oil was further purified by HPLC (YMC Hydro-
sphere C18, 150 ꢁ 20 mm, 70% MeOH, 8.0 ml minꢀ1, 254 nm) to
521.2843; [
a
]26D +24.7 (MeOH, c 0.146). (ꢀ)-Abz-E2B: 1H NMR
(270 MHz, CDCl3): d 0.68 (9H, s, t-butyl), 0.90 (3H, t, J = 7.3 Hz, –
OCH2CH2CH2CH3), 1.34 (2H, m, –OCH2CH2CH2CH3), 1.56 (2H, m,
–OCH2CH2CH2CH3), 3.46 (2H, t, J = 6.6 Hz, –OCH2CH2CH2CH3),
3.60–3.76 (8H, m, –OCH2CH2OCH2CH2O–), 4.35 (1H, d, J = 8.9 Hz,
HO-3), 4.60 (1H, d, J = 8.9 Hz, H-3), 4.80 (2H, s, 1,2,3-triazole-
CH2O–), 7.00 (1H, s, H-1), 7.56 (2H, m, 1-phenyl), 7.82 (2H, m, 1-
phenyl), 8.07 (2H, s, 1,2,4-triazole and 1,2,3-triazole, overlapped),
8.54 (1H, s, 1,2,4-triazole); 13C NMR (67.8 MHz, CDCl3): d 13.9
(–OCH2CH2CH2CH3), 19.3 (–OCH2CH2CH2CH3), 26.1 (methyls in
t-butyl), 31.7 (–OCH2CH2CH2CH3), 36.3 (tertiary carbon in t-butyl),
64.7, 70.0, 70.1, 70.6, and 70.7 (diethylene glycol linker), 71.2
(–OCH2CH2CH2CH3), 75.8 (C3), 120.6 (1,2,3-triazole), 120.7 (phe-
nyl), 127.5 (C1), 130.3 (phenyl), 134.3 (phenyl), 136.7 (phenyl),
137.7 (C2), 143.2 (1,2,4-triazole), 146.4 (1,2,3-triazole), 151.7
(1,2,4-triazole); HRMS (ESI-TOF, positive mode): calcd for
obtain Abz-E2B (2.8 mg, 5.6
same manner as the diastereomer A, the diastereomer B (15.6
mg, 21.8 mol) was hydrolyzed to release Abz-E2B (4.5 mg, 9.0
mol, 41%) as a colorless oil. Abz-E2B obtained from the diastereo-
lmol, 72%) as a colorless oil. In the
l
l
mers A and B were determined to be the (+)- and (ꢀ)-isomers,
respectively, on the basis of chiral HPLC analysis (see Section 4.3.2).
4.4. Water-solubility test
C
26H38N6O4Na [M+Na]+ 521.2852, found 521.2857; (+)-Abz-E2B:
MeOH solutions of test samples were put in a glass vial and con-
centrated in vacuo. Distilled water (2 mL) or MeOH (2 mL) was
added to the vial. After shaking several times and leaving to stand
½
a 2D7
ꢂ
ꢀ24.1 (MeOH, c 0.157). Protons of 1,2,4-triazole and 1,2,3-
triazole were assigned on the basis of an HMBC correlation: –N–
CH@C(N@N–)–CH2O–.
for 1 h, 5 lL of the solution was subjected to HPLC. HPLC conditions
were: ODS column, Hydrosphere C18 (150 ꢁ 6.0 mm, YMC); sol-
vent, 85% MeOH in H2O; flow rate, 1.0 mL minꢀ1; detection,
254 nm. Solubility (%) in water was calculated based on the in
water/in MeOH ratio of the HPLC peak area.
4.3.3. Preparation of R-MTPA-esters of the optically pure Abz-
E2B
To a stirred solution of ( )-Abz-E2B (50 mg, 100
pyridine-CH2Cl2 (1:1, 450 l) was added dimethylaminopyridine
(78.9 mg, 703 mol) and S- -methoxy- -(trifluoromethyl)phenyl-
acetyl chloride (MTPA-Cl) (55 l, 293 mol). After stirred for 6 h,
lmol) in dry
l
l
a
a
4.5. Preparation of recombinant enzymes
l
l
water was added to quench the reaction. The resulting mixture
was extracted with EtOAc (7 mL ꢁ 3). The organic layer was
washed with brine, dried over Na2SO4, and concentrated in vacuo.
The residual oil was purified by silica gel column chromatography
with 70% EtOAc in hexane to obtain R-MTPA-( )-Abz-E2B (55 mg,
4.5.1. Coexpression of recombinant Arabidopsis CYP707A3 and
Arabidopsis P450 reductase (ATR2) in E. coli
A truncated Arabidopsis CYP707A3 (707A3d28), which lacked
the putative membrane-spanning segment of the N-terminus, res-
idues 3-28, was constructed. Cells of E. coli strain BL21 were trans-
formed with the constructs pCW-CYP707A3d28 and pACYC-AR2.
Cultures (3 mL) were grown overnight in Luria-Bertani medium
63 lmol, 63%) as a pale yellow oil. R-MTPA-( )-Abz-E2B (55 mg)
was diastereomerically resolved by silicagel HPLC (YMC-Pack SIL-
06, 150 ꢁ 20 mm, 30% 2-propanol in hexane, 4.0 ml minꢀ1
,
supplemented with ampicillin (50
l
g mLꢀ1) and chloramphenicol
254 nm) and subsequently purified by chiral HPLC (Chiralpak AD-
H, 250 ꢁ 10 mm, Daicel; solvent, 20% EtOH in hexane; flow rate,
4 mL minꢀ1; detection, 254 nm) to obtain the diastereomer A (R-
MTPA-(ꢀ)-Abz-E2B, 15.6 mg) and the diastereomer B (R-MTPA-
(100
l
g mLꢀ1). Then, 50 mL of Terrific Broth medium supple-
mented with ampicillin (50 l lg
g mLꢀ1), chloramphenicol (100
mLꢀ1), and aminolevulic acid (0.5 mM) was inoculated with an ali-
quot of the overnight culture (0.5 mL). The culture was incubated